BioBoss

John Simboli

BioBoss is a podcast about leadership in the biopharma community. Hear directly from the founders and CEOs of today's most innovative companies. Listen in as Wyant Simboli Principal and branding veteran John Simboli poses the questions "What drives you? How do you create change? Why should people care?" to biopharma leaders and hear insights on this rapidly developing field.

Subscribe Listen in podnod RSS feed Show website

98 episodes
Updated Wednesday

Episodes98

Newest first

Jul 29, 2024 · 31 min
Steve Uden: Co-Founder and CEO of Rallybio
Steve Uden, co-founder and CEO of RallyBio, shares his insights about leadership in biopharma and how Rallybio is working to to profoundly change the odds for patients living with rare diseases.
May 21, 2024 · 36 min
Karine Rossignol: Co-Founder and CEO of Smart Immune
Karine Rossignol, co-founder and CEO of Smart Immune, shares her insights with BioBoss host John Simboli about leadership in biopharma and how Smart Immune is working to harness a patient's own thymus to re-arm the immune system against cancer and infection.
Apr 20, 2024 · 49 min
Erik Buntinx: Founder and CEO of ANeuroTech
Erik Buntinx, founder and CEO of ANeuroTech, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how ANeurotech is working to develop effective treatments, with minimal or no side-effects, for patients who suffer with depression
Mar 25, 2024 · 39 min
Helen Torley: CEO of Halozyme Therapeutics
Helen Torley, CEO of Halozyme Therapeutics, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Halozyme is working to reinvent the patient experience by easing the burden of treatment and improving patient outcomes.
Feb 24, 2024 · 21 min
James Graham: CEO of Recce Pharmaceuticals
James Graham, CEO of Recce Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Recce is working to develop a new class of synthetic anti-infectives designed to address the threat of antibiotic-resistant superbugs.
Jan 27, 2024 · 39 min
Mike Gaffney: CEO of Cellphire Therapeutics
Mike Gaffney, CEO of Cellphire Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Cellphire is working to save lives by bringing novel hemostatic products to patients in need.
Dec 16, 2023 · 36 min
David Baram: Founder and CEO of EmendoBio
David Barmam, founder and CEO of Emendio Biotherapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Emendo is working to evolve traditional CRISPR tools and create new nucleases customized to any genetic disease.
Dec 15, 2023 · 1 min
Welcome to Season 6 of BioBoss
BioBoss podcast host John Simboli reflects on Seasons 1-5 and invites listeners to Season 6 starting in January 2024
Nov 7, 2023 · 36 min
Anat Binur: Co-Founder and CEO of Ukko
Anat Binur, co-founder and CEO of Ukko, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how Ukko is working to improve the lives of people who suffer from food allergies.
Oct 6, 2023 · 28 min
Markku Jalkanen: Founder and CEO of Faron Pharmaceuticals
Markku Jalkanen, founder and CEO of Faron Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Faron is working to develop new immunotherapies to address unmet medical needs in cancer and improve patient lives.
Sep 11, 2023 · 46 min
Lisa Deschamps: CEO of AviadoBio
Lisa Deschamps, CEO of AviadoBio, shares her thoughts with BioBoss host John Simboli about leadership in biopharma and how AviadoBio is working to develop transformative medicines for patients living with debilitating and life-threatening neurodegenerative disorders.
Aug 12, 2023 · 32 min
Leonard Mazur: Founder and CEO of Citius Pharma
Leonard Mazur, founder and CEO of Citius Pharmaceuticals, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Citius is working to unlock the potential of first-in-class critical care therapeutics, with a pipeline of anti-infectives in oncology, adjunct cancer care and stem cell therapy.
Jul 1, 2023 · 39 min
Dario Neri: Co-Founder and CEO of Philogen
Dario Neri, co-founder and CEO of Philogen, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Philogen is working to discover and develop targeted therapies to treat cancer and chronic inflammation.
May 27, 2023 · 44 min
Naseem Amin: CEO of Orphalan
Naseem Amin, CEO of Orphalan, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Orphalan is working to transform rare disease treatment.
Apr 22, 2023 · 50 min
Hartmut Ehrlich: CEO of Abivax
Hartmut Ehrlich, CEO of Abivax, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Abivax is working to develop treatments modulating the body’s natural immune system to treat patients with chronic inflammatory diseases, viral infections and cancer.
Apr 1, 2023 · 41 min
Ivo Timmermans: Co-Founder and CEO of Pleco Therapeutics
Ivo Timmermans, co-founder and CEO of Pleco Therapeutics, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Pleco is working to develop breakthrough therapies that change the balance in the treatment of cancer.
Mar 4, 2023 · 39 min
Philipp Spycher: Co-Founder and CEO of Araris Biotech
Philipp Spycher, co-founder and CEO of Araris Biotech, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Araris is working to develop a linker technology for antibody-drug conjugates that enables attachment of any payload to ‘off the shelf’ antibodies without the need of prior antibody engineering.
Feb 4, 2023 · 39 min
Patrick Arensdorf: Founder and CEO of Exai Bio
Pat Arensdorf, founder and CEO of Exai Bio, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how Exai is working to develop a next-generation RNA-based platform to deliver actionable insight into cancer biology from a simple blood draw.
Jan 1, 2023 · 34 min
Josh Geballe: Managing Director of Yale Ventures
Josh Geballe, Managing Director of Yale Ventures, shares his thoughts with BioBoss host John Simboli about leadership and community building in biopharma. Yale Ventures is a new initiative created by Yale University to support and expand innovation and entrepreneurship across Yale university and throughout the greater New Haven region with the goal of helping to develop innovations that impact the world's greatest challenges.
Dec 31, 2022 · 1 min
Welcome to Season 5 of BioBoss
BioBoss podcast host John Simboli reflects on the success of seasons 1, 2 ,3 and 4 and welcomes listeners to listen in on his conversations about leadership with biopharma founders and CEOs in BioBoss season 5. John is delighted to open BioBoss season 5 with his conversation with Josh Geballe, Managing Director of Yale Ventures, who shares his thoughts about leadership, innovation, entrepreneurship and community building in biopharma and biotech. Yale Ventures is a new initiative created by Yale University to support and expand innovation and entrepreneurship across Yale university and throughout the greater New Haven region with the goal of helping to develop innovations that impact the world's greatest challenges.